ABBV stock has seen strong gains of 85% from levels of $90 in early January 2021 to around $165 now, vs. an increase of about ...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson & Johnson (NYSE:JNJ) is about to trade ex-dividend in the next 3 days. The ex-dividend ...

J&J JNJ stock has plunged 6.1% in a month, losing almost $24 billion of its market value. Though slowing sales in its MedTech ...

On Tuesday, Johnson & Johnson (JNJ) stock saw a decline, ending the day at $152.64 which represents a decrease of $-2.40 or -1.55% from the prior close of $155.04. The stock opened at $154.53 and ...

Johnson & Johnson faces uncertainty with speculation about RFK Jr. at HHS. Learn why JNJ stock remains a buy despite ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

On Friday, Johnson & Johnson (JNJ) stock saw a decline, ending the day at $155.47 which represents a decrease of $-1.26 or -0.80% from the prior close of $156.73. The stock opened at $157 and touched ...

Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated ...

During market volatility and economic downturns, investors often turn to stocks offering stable dividends and growth ...

Leerink Partners analyst David Risinger has maintained their bullish stance on JNJ stock, giving a Buy rating on November 14.Don't Miss our ...

Notably, the $205 average of analysts’ price estimate for ABBV, reflects over 20% upside from its current levels of around $165. While ABBV stock may outperform JNJ stock in the next three years ...

This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, Johnson & Johnson is expected ...